Introduction
The Glow Blend — a combination of BPC-157 (10mg), GHK-Cu (50mg), and TB-500 (10mg) per vial — represents a multi-mechanism approach to tissue repair and regeneration research. Each component targets distinct but complementary biological pathways.
Why Researchers Study This Combination
BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide studied for angiogenesis, VEGFR2 signaling, and gastrointestinal and musculoskeletal tissue repair. See our BPC-157 research overview.
GHK-Cu (copper peptide) activates tissue remodeling pathways, stimulates collagen synthesis, and modulates gene expression related to inflammation and oxidative stress. See our GHK-Cu research overview.
TB-500 (Thymosin Beta-4) is an actin-sequestering peptide that promotes cell migration, angiogenesis, and tissue regeneration. See our TB-500 research overview.
Quality Considerations for Combination Peptide Products
A legitimate COA for a combination product should verify the identity and purity of each individual component separately, the total peptide content per vial, absence of cross-contamination between components, and endotoxin levels for the combined preparation. Be cautious of combination products that provide only a single purity figure without component-level breakdown.
Pure Pharm Peptides Glow Blend
Pure Pharm Peptides supplies the Glow Blend (BPC-157 10mg + GHK-Cu 50mg + TB-500 10mg, 70mg total per vial, 10 vials per kit) with independent USA laboratory COA verification. View the Glow Blend product page for current batch documentation and component-level purity data.
---
All products are for research purposes only and are not intended for human or animal consumption.
See Also: BPC-157 vs TB-500 vs GHK-Cu Comparison · GHK-Cu Research · Peptide Research for Skin Aging